Morningside Pharmaceuticals Ltd has appointed new chief operating officer (COO) and chief financial officer (CFO) who ipso facto become members of the company’s board and governance committees.
Monica Huang has been promoted into the role of COO, while Cliff Fung joins Morningside as the new CFO.
Huang joined the company 12 years ago as an administrator, progressing to general manager and then operations director in 2017.
Fung has over 25 years’ experience of working in senior finance roles within the pharmaceutical sector. Previous to joining Morningside, he was a finance director at Aesica Pharmaceuticals.
Commenting on the new appointments, Dr Nik Kotecha OBE, the chief executive of Morningside Pharmaceuticals, said: “I am very pleased to welcome both Cliff and Monica onto the board of directors.
“We are beginning an exciting new chapter at Morningside, where the skills, experience and expertise of both individuals will be critical to delivering our ambitious future plans.”
